Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Aromatase gene amplification

Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy
Aromatase gene amplification ( Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy )
19 Jun 2017

Informed patients are empowered patients

Prof Gabriella Pravettoni - European Institute of Oncology, Milan, Italy
Informed patients are empowered patients ( Prof Gabriella Pravettoni - European Institute of Oncology, Milan, Italy )
19 Jun 2017

Europa Uomo - improving prostate cancer patients quality of life across Europe

Prof Louis Denis - Europa Uomo, Belgium
Europa Uomo - improving prostate cancer patients quality of life across Europe ( Prof Louis Denis - Europa Uomo, Belgium )
19 Jun 2017

Personalised medicine for rare cancers

Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy
Personalised medicine for rare cancers ( Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy )
19 Jun 2017

Clinical potential of trastuzumab biosimilar CTP6

Prof Francisco Esteva - NYU Langone Medical Center, New York, USA
Clinical potential of trastuzumab biosimilar CTP6 ( Prof Francisco Esteva - NYU Langone Medical Center, New York, USA )
8 Jun 2017

Updates in melanoma: Treating BRAF and brain metastases

Prof Georgina Long - University of Sydney, Sydney, Australia
Updates in melanoma: Treating BRAF and brain metastases ( Prof Georgina Long - University of Sydney, Sydney, Australia )
5 Jun 2017

Bendamustine for indolent lymphoma reduces relapse after 10 years

Dr Mathias Rummel - University of Giessen, Giessen, Germany
Bendamustine for indolent lymphoma reduces relapse after 10 years ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )
5 Jun 2017

ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year

Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year ( Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy )
5 Jun 2017

T-VEC and checkpoint therapy for melanoma

Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA
T-VEC and checkpoint therapy for melanoma ( Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )
5 Jun 2017

Dacomitinib for EGFR positive lung cancer

Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China
Dacomitinib for EGFR positive lung cancer ( Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China )
5 Jun 2017

Treating advanced melanoma with ipilimumab and HF10

Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA
Treating advanced melanoma with ipilimumab and HF10 ( Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )
5 Jun 2017

Alectinib eclipses crizotinib for ALK positive lung cancer

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Alectinib eclipses crizotinib for ALK positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
5 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation